Genetics and Genomics in 2013

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface

• A J Lee
• A P Cunningham
• A C Antoniou

HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma

• L-p Liu
• B-g Hu
• P B S Lai

Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling

• S R Lambert
• N Mladkova
• C A Harwood

An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma

• A Linton
• Y Y Cheng
• G Reid

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study

• C M Phelan
• J Iqbal
• Tomasz Huzarski

Strong reduction of AGO2 expression in melanoma and cellular consequences

• D Völler
• J Reinders
• A-K Bosserhoff

Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex

• B Giessrigl
• W M Schmidt
• G Krupitza

Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression

• X Tan
• Y Wang
• G Cao

DICER1 hotspot mutations in non-epithelial gonadal tumours

• L Witkowski
• J Mattina
• W D Foulkes

ALK gene amplification is associated with poor prognosis in colorectal carcinoma

• P Bavi
• Z Jehan
• K S Al-Kuraya

MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours

• M Tanic
• E Andrés
• B Martinez-Delgado

Iodine-131 dose-dependent gene expression: alterations in both normal and tumour thyroid tissues of post-Chernobyl thyroid cancers

• M Abend
• R M Pfeiffer
• A V Brenner

The clinical implication of SS18 -SSX fusion gene in synovial sarcoma

• T Ren
• Q Lu
• Y Sun

Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma

• X Li
• Z Wu
• W Han

Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas

• A Akiyama-Abe
• T Minaguchi
• H Yoshikawa

Evolutionary game theory of growth factor production: implications for tumour heterogeneity and resistance to therapies

• M Archetti

Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions

• D H Moon
• J-M Lee
• E C Kohn

DUSP6 regulates drug sensitivity by modulating DNA damage response

• T V Bagnyukova
• D Restifo
• I Astsaturov

miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1

• Y Iwagami
• H Eguchi
• Y Doki

Estimating single nucleotide polymorphism associations using pedigree data: applications to breast cancer

• D R Barnes
• D Barrowdale
• G Mitchell